Source: Blood. Conference titles: Annual Meeting and Exposition / ASH. Unidade: FM
Subjects: LINFOMA (TERAPIA), FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAGE, Luis Alberto de Padua C. et al. Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era. Blood. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://www.hematology.org/Annual-Meeting/Program/Education-Program.aspx. Acesso em: 01 jun. 2024. , 2014APA
Lage, L. A. de P. C., Costa, R. O., Hollack Neto, A. E., Siqueira, S., Paula, H. M., Santucci, R., & Pereira, J. (2014). Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era. Blood. New York: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://www.hematology.org/Annual-Meeting/Program/Education-Program.aspxNLM
Lage LA de PC, Costa RO, Hollack Neto AE, Siqueira S, Paula HM, Santucci R, Pereira J. Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era [Internet]. Blood. 2014 ; 124( 21):[citado 2024 jun. 01 ] Available from: http://www.hematology.org/Annual-Meeting/Program/Education-Program.aspxVancouver
Lage LA de PC, Costa RO, Hollack Neto AE, Siqueira S, Paula HM, Santucci R, Pereira J. Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era [Internet]. Blood. 2014 ; 124( 21):[citado 2024 jun. 01 ] Available from: http://www.hematology.org/Annual-Meeting/Program/Education-Program.aspx